Recent insights into contributing factors in the pathogenesis of cirrhotic ascites

Zhen Li1, Junfeng Zhu1,2, Hao Ouyang1

  • 1Department of Hepatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Frontiers in Medicine
|September 30, 2024
PubMed

Insights

Cirrhotic ascites, fluid accumulation from liver disease, lacks effective treatments. This study explores its complex pathogenesis, including portal hypertension and gut microbiota, for better understanding.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Cirrhotic ascites is fluid accumulation in the peritoneal cavity due to severe liver disease and impaired function.
  • It is a common cirrhosis complication, posing significant health threats and social burdens globally.
  • Current treatments only manage symptoms and slow progression, lacking curative options.

Purpose of the Study:

  • To examine the pathogenesis of cirrhotic ascites.
  • To explore contributing factors including portal hypertension, renal dysfunction, inflammation, growth factors, oxidative stress, immunocytes, and gut microbiota.
  • To gain deeper insights into the mechanisms underlying cirrhotic ascites.

Main Methods:

  • Literature review and synthesis of existing research on cirrhotic ascites.
  • Analysis of factors contributing to fluid accumulation and disease progression.
  • Exploration of the interplay between various pathophysiological mechanisms.

Main Results:

  • Cirrhotic ascites results from complex interactions including portal hypertension, altered hemodynamics, and fluid exudation.
  • Renal dysfunction, inflammation, oxidative stress, and immune cell activity play crucial roles.
  • Gut microbiota dysbiosis is increasingly recognized as a significant contributing factor.

Conclusions:

  • Understanding the multifaceted pathogenesis of cirrhotic ascites is critical for developing effective therapeutic strategies.
  • Targeting factors like portal hypertension, inflammation, and gut microbiota may offer new treatment avenues.
  • Further research into these mechanisms is essential to improve patient outcomes and quality of life.

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
76
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
485
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
48
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
83
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
194
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
156